{"id":745295,"date":"2016-11-29T07:00:00","date_gmt":"2016-11-29T07:00:00","guid":{"rendered":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/actress-bellamy-young-merck-and-leading-lung-cancer-advocates-urge-those-impacted-by-lung-cancer-to-test-talk-take-action\/"},"modified":"2025-11-07T01:25:31","modified_gmt":"2025-11-07T06:25:31","slug":"actress-bellamy-young-merck-and-leading-lung-cancer-advocates-urge-those-impacted-by-lung-cancer-to-test-talk-take-action","status":"publish","type":"news_item","link":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/actress-bellamy-young-merck-and-leading-lung-cancer-advocates-urge-those-impacted-by-lung-cancer-to-test-talk-take-action\/","title":{"rendered":"Actress Bellamy Young, Merck, and Leading Lung Cancer Advocates Urge Those Impacted by Lung Cancer to Test. Talk. Take Action."},"content":{"rendered":"<p class=\"bwalignc\">       Young to Help Educate on the Importance of Biomarker Testing in        Non-Small Cell Lung Cancer     <\/p>\n<\/p>\n<p>KENILWORTH, N.J.&#8211;(<a target=\"_blank\" href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;Acclaimed actress and singer<i> <\/i>Bellamy Young lost her father to<br \/>\n      lung cancer, and she is now sharing her personal experience as part of <i>Test.<br \/>\n      Talk. Take Action<\/i>., a new awareness campaign focused on increasing<br \/>\n      people\u2019s understanding of biomarkers and the role they play in the<br \/>\n      treatment of non-small cell lung cancer (NSCLC). The campaign \u2013 led by<br \/>\n      Merck (NYSE:MRK), known as MSD outside the United States and Canada, in<br \/>\n      partnership with Young and leading lung cancer advocacy groups \u2013<br \/>\n      encourages those impacted by NSCLC to learn about biomarkers and talk<br \/>\n      with their health care provider about testing.\n    <\/p>\n<p>\n      Biomarkers, substances that can be found in cancer cells, give doctors a<br \/>\n      more well-defined picture of a patient\u2019s lung cancer. In addition to<br \/>\n      being used to diagnose cancer, testing for biomarkers can help doctors<br \/>\n      make informed decisions about the most appropriate treatment for a<br \/>\n      patient\u2019s lung cancer. There are several different biomarkers that can<br \/>\n      be used to plan treatment in NSCLC. These include EGFR, ALK, ROS-1, and<br \/>\n      PD-L1.\n    <\/p>\n<p>\n      \u201cOne of the most important parts of the lung cancer journey is becoming<br \/>\n      informed about what you and your loved ones are facing,\u201d Young<br \/>\n      explained. \u201cWhen my Pop was diagnosed with lung cancer, we felt helpless<br \/>\n      and confused. At the time, I just wanted more resources to help us<br \/>\n      understand and manage his treatment and care.\u201d\n    <\/p>\n<p>\n      Leading lung cancer patient advocacy groups supporting the program<br \/>\n      include Bonnie J. Addario Lung Cancer Foundation, Free to Breathe, Lung<br \/>\n      Cancer Alliance, Lung Cancer Foundation of America, Lung Cancer Research<br \/>\n      Foundation, and LUNGevity. These organizations have made it their<br \/>\n      mission to support people impacted by lung cancer through education,<br \/>\n      resources and research.\n    <\/p>\n<p>\n      Young knows firsthand what people with lung cancer and their loved ones<br \/>\n      are going through; her father went through 10 months of treatment before<br \/>\n      he passed away from the disease.\n    <\/p>\n<p>\n      She added, \u201cI\u2019m honored to be a part of a campaign that is designed to<br \/>\n      provide people impacted by NSCLC with information that can help empower<br \/>\n      them to make informed treatment decisions. I encourage patients and<br \/>\n      their loved ones to visit <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.TestTalkTakeAction.com&amp;esheet=51467298&amp;newsitemid=20161129005504&amp;lan=en-US&amp;anchor=www.TestTalkTakeAction.com&amp;index=1&amp;md5=50b97e88d9ce6a9738552f963ddcc8dd\" rel=\"nofollow\">www.TestTalkTakeAction.com<\/a><br \/>\n      to get the facts about biomarker testing and start a new dialogue with<br \/>\n      their health care providers about the next steps in their treatment.\u201d\n    <\/p>\n<p>\n      <b>Lung Cancer and the Role of Biomarker Testing<\/b>\n    <\/p>\n<p>\n      Lung cancer, which forms in the tissues of the lungs, usually within<br \/>\n      cells lining the air passages, is the leading cause of cancer death<br \/>\n      worldwide. Each year, more people die of lung cancer than colon, breast,<br \/>\n      and prostate cancers combined. The two main types of lung cancer are<br \/>\n      non-small cell and small cell. NSCLC is the most common type of lung<br \/>\n      cancer, accounting for about 85 percent of all cases.\n    <\/p>\n<p>\n      Thanks to advancements in lung cancer research, doctors have found that<br \/>\n      every lung cancer is different and that they can use biomarker testing<br \/>\n      to uncover some of the characteristics of a patient\u2019s cancer. Biomarker<br \/>\n      testing is now widely recommended in NSCLC and by testing, doctors can<br \/>\n      use the information to plan the best treatment path forward for a<br \/>\n      patient.\n    <\/p>\n<p>\n      \u201cEveryday scientists are learning more and more about lung cancer,<br \/>\n      including how biomarker testing can play an increasingly important role<br \/>\n      in the care of people with NSCLC,\u201d said Dr. Suman Bannur Rao, medical<br \/>\n      oncologist at MedStar Franklin Square Medical Center in Baltimore,<br \/>\n      Maryland. \u201cThe results of biomarker testing can provide critical<br \/>\n      information that enables us to determine the specific treatments that<br \/>\n      are more likely to work for a patient.\u201d\n    <\/p>\n<p>\n      \u201cAt Merck, we\u2019re committed to helping patients affected by lung cancer,<br \/>\n      which includes developing resources to increase understanding about this<br \/>\n      disease,\u201d said Jill DeSimone, senior vice president, Merck Oncology. \u201cWe<br \/>\n      are excited to work with the lung cancer community and Bellamy Young on <i>Test.<br \/>\n      Talk. Take Action.<\/i> and hope that through education, we can help<br \/>\n      inspire patients to be their own health care advocate by talking with<br \/>\n      their doctor about biomarker testing and making informed treatment<br \/>\n      decisions.\u201d\n    <\/p>\n<p>\n      To learn more about comprehensive biomarker testing in NSCLC, including<br \/>\n      PD-L1, talk to your doctor, and visit <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.TestTalkTakeAction.com&amp;esheet=51467298&amp;newsitemid=20161129005504&amp;lan=en-US&amp;anchor=www.TestTalkTakeAction.com&amp;index=2&amp;md5=c3d140dc083d2687efe95cf613fa2e73\" rel=\"nofollow\">www.TestTalkTakeAction.com<\/a>.\n    <\/p>\n<p>\n      <b>About <i>Test. Talk. Take Action.<\/i><br \/>\n<\/b>\n    <\/p>\n<p>\n      <i>Test. Talk. Take Action<\/i> encourages those impacted by NSCLC to<br \/>\n      make informed treatment decisions by learning about biomarkers and<br \/>\n      talking with their health care provider about biomarker testing.\n    <\/p>\n<p>\n      Biomarkers are like pieces to a puzzle that give doctors a more<br \/>\n      well-defined picture of a patient\u2019s lung cancer. In addition to being<br \/>\n      used to diagnose cancer, the results of a biomarker test can also help<br \/>\n      doctors make informed decisions about the most appropriate treatment for<br \/>\n      a patient. In NSCLC, doctors test for the biomarkers EGFR, ALK, ROS-1,<br \/>\n      and PD-L1 to inform a patient\u2019s treatment path forward.\n    <\/p>\n<p>\n      To learn more about comprehensive biomarker testing in NSCLC, visit <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.TestTalkTakeAction.com&amp;esheet=51467298&amp;newsitemid=20161129005504&amp;lan=en-US&amp;anchor=www.TestTalkTakeAction.com&amp;index=3&amp;md5=71c6bf80a9a42e99d5d8b69bdab63deb\" rel=\"nofollow\">www.TestTalkTakeAction.com<\/a>.\n    <\/p>\n<p>\n      <b>About Bellamy Young<\/b>\n    <\/p>\n<p>\n      Acclaimed actress and singer Bellamy Young is currently starring in her<br \/>\n      award-winning role on one of Thursday night\u2019s top-rated drama series.<br \/>\n      Young has appeared in several major television and film roles, including <i>Criminal<br \/>\n      Minds, Dirty, Sexy, Money; CSI: Miami, Another World, We Were Soldiers <\/i>and<br \/>\n      <i>Mission Impossible: III<\/i>, <i>Night Stalker<\/i>, and will star in<br \/>\n      the indie picture <i>Offer &amp; Compromise<\/i>. Young recently released<br \/>\n      her debut album, <i>Far Away So Close<\/i>, a collection of contemporary<br \/>\n      covers influenced by her North Carolina roots. Her professional<br \/>\n      achievements include a Critics\u2019 Choice Television Award for Best<br \/>\n      Supporting Actress, in addition to numerous other honors throughout her<br \/>\n      career.\n    <\/p>\n<p>\n      <b>About the Bonnie J. Addario Lung Cancer Foundation<\/b>\n    <\/p>\n<p>\n      The Bonnie J. Addario Lung Cancer Foundation (ALCF) is one of the<br \/>\n      largest philanthropies (patient-founded, patient-focused, and<br \/>\n      patient-driven) devoted exclusively to eradicating Lung Cancer through<br \/>\n      research, early detection, education, and treatment. The Foundation\u2019s<br \/>\n      goal is to work with a diverse group of physicians, organizations,<br \/>\n      industry partners, individuals, patients, survivors, and their families<br \/>\n      to identify solutions and make timely and meaningful change and turn<br \/>\n      lung cancer into a chronically managed disease by 2023. The ALCF was<br \/>\n      established on March 1, 2006 as a 501c(3) non-profit organization and<br \/>\n      has raised nearly $30 million for lung cancer research and related<br \/>\n      programs. For more information about the ALCF please visit <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.lungcancerfoundation.org%2F&amp;esheet=51467298&amp;newsitemid=20161129005504&amp;lan=en-US&amp;anchor=http%3A%2F%2Fwww.lungcancerfoundation.org%2F&amp;index=4&amp;md5=a18d2969326afca9353886d942081765\" rel=\"nofollow\">http:\/\/www.lungcancerfoundation.org\/<\/a><br \/>\n      or follow ALCF on Facebook or Twitter.\n    <\/p>\n<p>\n      <b>About Free to Breathe<\/b>\n    <\/p>\n<p>\n      Free to Breathe, a 501(c)(3) non-profit organization, was founded in<br \/>\n      2001 and officially incorporated in 2003. Free to Breathe is a<br \/>\n      partnership of lung cancer survivors, advocates, researchers, health<br \/>\n      care professionals and industry leaders dedicated to doubling lung<br \/>\n      cancer survival by 2022. To ensure that surviving lung cancer is the<br \/>\n      expectation, not the exception, Free to Breathe focuses on funding<br \/>\n      research with the greatest potential to save lives, and building the<br \/>\n      lung cancer community. Our toll-free Support Line (844.835.4325)<br \/>\n      provides education, connection to local and national resources, and<br \/>\n      opportunities for meaningful engagement to help patients and caregivers<br \/>\n      facing lung cancer. For more information, visit <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.freetobreathe.org&amp;esheet=51467298&amp;newsitemid=20161129005504&amp;lan=en-US&amp;anchor=http%3A%2F%2Fwww.freetobreathe.org&amp;index=5&amp;md5=08073ba9d7180432e57dee441038bebb\" rel=\"nofollow\">http:\/\/www.freetobreathe.org<\/a>.<br \/>\n      Free to Breathe is \u201cBest Charities in America\u201d certified.\n    <\/p>\n<p>\n      <b>About Lung Cancer Alliance<\/b>\n    <\/p>\n<p>\n      Lung Cancer Alliance (LCA), the highest rated lung cancer charity in the<br \/>\n      country, is committed to saving lives and accelerating research and<br \/>\n      policy while empowering people living with or at risk for lung cancer.<br \/>\n      LCA provides live, professional support, referral and information<br \/>\n      services to patients, their loved ones and those at risk for lung<br \/>\n      cancer; conducts national awareness campaigns attacking the stigma of<br \/>\n      the disease, spreading the word about risk and screening and educating<br \/>\n      those diagnosed about options and where to go for help; and advocates<br \/>\n      for multiple millions in public health dollars for lung cancer research.\n    <\/p>\n<p>\n      <b>About Lung Cancer Foundation of America (LCFA)<\/b>\n    <\/p>\n<p>\n      LCFA\u2019s mission is the dramatic improvement in survivorship of lung<br \/>\n      cancer patients through the funding of transformative science, with the<br \/>\n      ultimate goal of curing the disease.\n    <\/p>\n<p>\n      To accomplish this, LCFA will work to raise&nbsp;both the funds, and the<br \/>\n      national profile of lung cancer through their \u201c30 Days 30 Ways\u201d and \u201cThe<br \/>\n      Little Things\u201d campaigns,&nbsp;in order to substantially increase support of<br \/>\n      innovative and groundbreaking research efforts. Learn more about the<br \/>\n      Foundation at <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.lcfamerica.org%2F&amp;esheet=51467298&amp;newsitemid=20161129005504&amp;lan=en-US&amp;anchor=www.lcfamerica.org%2F&amp;index=6&amp;md5=1628011ea828da5330bcc28e89958f1a\" rel=\"nofollow\">www.lcfamerica.org\/<\/a>.\n    <\/p>\n<p>\n      <b>About The Lung Cancer Research Foundation<\/b>\n    <\/p>\n<p>\n      The mission of the Lung Cancer Research Foundation is to improve and<br \/>\n      save lives by funding groundbreaking research for the prevention,<br \/>\n      diagnosis, treatment and cure of lung cancer. To date, the Lung Cancer<br \/>\n      Research Foundation has funded hundreds of grants totaling $23 million<br \/>\n      across the spectrum of basic, clinical and translational research at<br \/>\n      leading medical institutions around the world.\n    <\/p>\n<p>\n      <b>About LUNGevity Foundation<\/b>\n    <\/p>\n<p>\n      LUNGevity Foundation is firmly committed to making an immediate impact<br \/>\n      on increasing quality of life and survivorship of people with lung<br \/>\n      cancer by accelerating research into early detection and more effective<br \/>\n      treatments, as well as by providing community, support, and education<br \/>\n      for all those affected by the disease. The Foundation collaborates with<br \/>\n      survivors, researchers, physicians, government agencies and corporate<br \/>\n      and nonprofit partners to meet the unmet needs of lung cancer patients<br \/>\n      and their families. LUNGevity&#8217;s vision is a world where no one dies of<br \/>\n      lung cancer. For more information about LUNGevity Foundation, please<br \/>\n      visit <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.LUNGevity.org&amp;esheet=51467298&amp;newsitemid=20161129005504&amp;lan=en-US&amp;anchor=www.LUNGevity.org&amp;index=7&amp;md5=0c29963dd9af37289c51f54fa0d422d0\" rel=\"nofollow\">www.LUNGevity.org<\/a>.\n    <\/p>\n<p>\n      <b>Merck\u2019s Focus on Cancer<\/b>\n    <\/p>\n<p>\n      Our goal is to translate breakthrough science into innovative oncology<br \/>\n      medicines to help people with cancer worldwide. At Merck Oncology,<br \/>\n      helping people fight cancer is our passion and supporting accessibility<br \/>\n      to our cancer medicines is our commitment. Our focus is on pursuing<br \/>\n      research in immuno-oncology and we are accelerating every step in the<br \/>\n      journey&nbsp;\u2013 from lab to clinic&nbsp;\u2013 to potentially bring new hope to people<br \/>\n      with cancer.\n    <\/p>\n<p>\n      <b>About Merck<\/b>\n    <\/p>\n<p>\n      For 125 years, Merck has been a global health care leader working to<br \/>\n      help the world be well. Merck is known as MSD outside the United States<br \/>\n      and Canada. Through our prescription medicines, vaccines, biologic<br \/>\n      therapies and animal health products, we work with customers and operate<br \/>\n      in more than 140 countries to deliver innovative health solutions. We<br \/>\n      also demonstrate our commitment to increasing access to health care<br \/>\n      through far-reaching policies, programs and partnerships. For more<br \/>\n      information, visit <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fvip2-msd.com\/merckcom-migrated%2F&amp;esheet=51467298&amp;newsitemid=20161129005504&amp;lan=en-US&amp;anchor=vip2-msd.com\/merckcom-migrated&amp;index=8&amp;md5=9d6b88aaaa8ddc2572750c517e54fec5\" rel=\"nofollow\">vip2-msd.com\/merckcom-migrated<\/a><br \/>\n      and connect with us on <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FMerck&amp;esheet=51467298&amp;newsitemid=20161129005504&amp;lan=en-US&amp;anchor=Twitter&amp;index=9&amp;md5=a3803ff02c18808904483ed71fcf673e\" rel=\"nofollow\">Twitter<\/a>,<br \/>\n      <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.facebook.com%2FMerckBeWell&amp;esheet=51467298&amp;newsitemid=20161129005504&amp;lan=en-US&amp;anchor=Facebook&amp;index=10&amp;md5=c9de2bfc810dd5c571aa3abad319e268\" rel=\"nofollow\">Facebook<\/a>,<br \/>\n      <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.youtube.com%2FMerck&amp;esheet=51467298&amp;newsitemid=20161129005504&amp;lan=en-US&amp;anchor=YouTube&amp;index=11&amp;md5=45b5147dc744bed13b4041518078aa83\" rel=\"nofollow\">YouTube<\/a><br \/>\n      and <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fmerck&amp;esheet=51467298&amp;newsitemid=20161129005504&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=12&amp;md5=7f7fae6e744124c5d0dd729238bc935b\" rel=\"nofollow\">LinkedIn<\/a>.\n    <\/p>\n<p class=\"bwalignc\">\n<p>\n<img decoding=\"async\" alt=\"\" src=\"\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20161129005504r1&amp;sid=hq1sc1&amp;distro=nx&amp;lang=en\"><br \/>\n<span class=\"bwct31415\"><br \/>\n<\/span><\/p>\n<p>       Media<br \/>Merck<br \/>Courtney Ronaldo, 908-236-1108<br \/>or<br \/>Christiana        Pascale, 212-257-6722     <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Acclaimed actress and singer Bellamy Young lost her father to lung cancer, and she is now sharing her personal experience as part of Test. Talk. Take Action ., a new awareness campaign focused on increasing people\u2019s understanding of biomarkers and the role they play in the treatment of non-small cell lung cancer (NSCLC). The campaign \u2013 led by Merck (NYSE:MRK), known as MSD outside the United States and Canada, in partnership with Young and leading lung cancer advocacy groups \u2013 encourages those impacted by NSCLC to learn about biomarkers and talk with their health care provider about testing. Biomarkers, substances that can be found in cancer cells, give doctors a more well-defined picture of a patient\u2019s lung cancer. In addition to being used to diagnose cancer, testing for biomarkers can help doctors make informed decisions about the most appropriate treatment for a patient\u2019s lung cancer. There are several different biomarkers that can be used to plan treatment in NSCLC. These include<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"bdl_company_name":[],"bdl_item_external_link":[],"inpsyde_pem_expiration_date":[],"inpsyde_pem_expiration_action":[],"footnotes":""},"tags":[53,64,137,138,289],"class_list":["post-745295","news_item","type-news_item","status-publish","hentry","tag-corporate-news","tag-latest-news","tag-oncology","tag-oncology-newsroom","tag-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Actress Bellamy Young, Merck, and Leading Lung Cancer Advocates Urge Those Impacted by Lung Cancer to Test. Talk. Take Action. - Merck.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/actress-bellamy-young-merck-and-leading-lung-cancer-advocates-urge-those-impacted-by-lung-cancer-to-test-talk-take-action\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Actress Bellamy Young, Merck, and Leading Lung Cancer Advocates Urge Those Impacted by Lung Cancer to Test. Talk. Take Action. - Merck.com\" \/>\n<meta property=\"og:description\" content=\"Acclaimed actress and singer Bellamy Young lost her father to lung cancer, and she is now sharing her personal experience as part of Test. Talk. Take Action ., a new awareness campaign focused on increasing people\u2019s understanding of biomarkers and the role they play in the treatment of non-small cell lung cancer (NSCLC). The campaign \u2013 led by Merck (NYSE:MRK), known as MSD outside the United States and Canada, in partnership with Young and leading lung cancer advocacy groups \u2013 encourages those impacted by NSCLC to learn about biomarkers and talk with their health care provider about testing. Biomarkers, substances that can be found in cancer cells, give doctors a more well-defined picture of a patient\u2019s lung cancer. In addition to being used to diagnose cancer, testing for biomarkers can help doctors make informed decisions about the most appropriate treatment for a patient\u2019s lung cancer. There are several different biomarkers that can be used to plan treatment in NSCLC. These include\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/actress-bellamy-young-merck-and-leading-lung-cancer-advocates-urge-those-impacted-by-lung-cancer-to-test-talk-take-action\/\" \/>\n<meta property=\"og:site_name\" content=\"Merck.com\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-07T06:25:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-content\/uploads\/sites\/152\/2022\/03\/Merck.png\" \/>\n\t<meta property=\"og:image:width\" content=\"3056\" \/>\n\t<meta property=\"og:image:height\" content=\"1380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/actress-bellamy-young-merck-and-leading-lung-cancer-advocates-urge-those-impacted-by-lung-cancer-to-test-talk-take-action\\\/\",\"url\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/actress-bellamy-young-merck-and-leading-lung-cancer-advocates-urge-those-impacted-by-lung-cancer-to-test-talk-take-action\\\/\",\"name\":\"Actress Bellamy Young, Merck, and Leading Lung Cancer Advocates Urge Those Impacted by Lung Cancer to Test. Talk. Take Action. - Merck.com\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/#website\"},\"datePublished\":\"2016-11-29T07:00:00+00:00\",\"dateModified\":\"2025-11-07T06:25:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/actress-bellamy-young-merck-and-leading-lung-cancer-advocates-urge-those-impacted-by-lung-cancer-to-test-talk-take-action\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/actress-bellamy-young-merck-and-leading-lung-cancer-advocates-urge-those-impacted-by-lung-cancer-to-test-talk-take-action\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/actress-bellamy-young-merck-and-leading-lung-cancer-advocates-urge-those-impacted-by-lung-cancer-to-test-talk-take-action\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"News\",\"item\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news-archive\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Actress Bellamy Young, Merck, and Leading Lung Cancer Advocates Urge Those Impacted by Lung Cancer to Test. Talk. Take Action.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/#website\",\"url\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/\",\"name\":\"Merck.com\",\"description\":\"Just another vip-msd.com site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Actress Bellamy Young, Merck, and Leading Lung Cancer Advocates Urge Those Impacted by Lung Cancer to Test. Talk. Take Action. - Merck.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/actress-bellamy-young-merck-and-leading-lung-cancer-advocates-urge-those-impacted-by-lung-cancer-to-test-talk-take-action\/","og_locale":"en_US","og_type":"article","og_title":"Actress Bellamy Young, Merck, and Leading Lung Cancer Advocates Urge Those Impacted by Lung Cancer to Test. Talk. Take Action. - Merck.com","og_description":"Acclaimed actress and singer Bellamy Young lost her father to lung cancer, and she is now sharing her personal experience as part of Test. Talk. Take Action ., a new awareness campaign focused on increasing people\u2019s understanding of biomarkers and the role they play in the treatment of non-small cell lung cancer (NSCLC). The campaign \u2013 led by Merck (NYSE:MRK), known as MSD outside the United States and Canada, in partnership with Young and leading lung cancer advocacy groups \u2013 encourages those impacted by NSCLC to learn about biomarkers and talk with their health care provider about testing. Biomarkers, substances that can be found in cancer cells, give doctors a more well-defined picture of a patient\u2019s lung cancer. In addition to being used to diagnose cancer, testing for biomarkers can help doctors make informed decisions about the most appropriate treatment for a patient\u2019s lung cancer. There are several different biomarkers that can be used to plan treatment in NSCLC. These include","og_url":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/actress-bellamy-young-merck-and-leading-lung-cancer-advocates-urge-those-impacted-by-lung-cancer-to-test-talk-take-action\/","og_site_name":"Merck.com","article_modified_time":"2025-11-07T06:25:31+00:00","og_image":[{"width":3056,"height":1380,"url":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-content\/uploads\/sites\/152\/2022\/03\/Merck.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/actress-bellamy-young-merck-and-leading-lung-cancer-advocates-urge-those-impacted-by-lung-cancer-to-test-talk-take-action\/","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/actress-bellamy-young-merck-and-leading-lung-cancer-advocates-urge-those-impacted-by-lung-cancer-to-test-talk-take-action\/","name":"Actress Bellamy Young, Merck, and Leading Lung Cancer Advocates Urge Those Impacted by Lung Cancer to Test. Talk. Take Action. - Merck.com","isPartOf":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website"},"datePublished":"2016-11-29T07:00:00+00:00","dateModified":"2025-11-07T06:25:31+00:00","breadcrumb":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/actress-bellamy-young-merck-and-leading-lung-cancer-advocates-urge-those-impacted-by-lung-cancer-to-test-talk-take-action\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vip2-msd.com\/merckcom-migrated\/news\/actress-bellamy-young-merck-and-leading-lung-cancer-advocates-urge-those-impacted-by-lung-cancer-to-test-talk-take-action\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/actress-bellamy-young-merck-and-leading-lung-cancer-advocates-urge-those-impacted-by-lung-cancer-to-test-talk-take-action\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"News","item":"https:\/\/vip2-msd.com\/merckcom-migrated\/news-archive\/"},{"@type":"ListItem","position":2,"name":"Actress Bellamy Young, Merck, and Leading Lung Cancer Advocates Urge Those Impacted by Lung Cancer to Test. Talk. Take Action."}]},{"@type":"WebSite","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/","name":"Merck.com","description":"Just another vip-msd.com site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vip2-msd.com\/merckcom-migrated\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":{"news_item_workflow_id":"2de2720c-9959-496e-8fd0-bb6f75d67605","news_item_aria_label":"","media_files":[{"path":"https:\/\/s2.q4cdn.com\/584635680\/files\/doc_events\/2016\/11\/1\/Merck_TTTA_Twitter_Website.jpg","size":"113322","File Upload":""},{"path":"https:\/\/s2.q4cdn.com\/584635680\/files\/doc_events\/2016\/11\/1\/merck_logo.jpg","size":"21167","File Upload":""}],"document_path":"https:\/\/s2.q4cdn.com\/584635680\/files\/doc_news\/Actress-Bellamy-Young-Merck-and-Leading-Lung-Cancer-Advocates-Urge-Those-Impacted-by-Lung-Cancer-to-Test-Talk-Take-Action-2016.pdf","file":""},"_links":{"self":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/745295","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item"}],"about":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/types\/news_item"}],"version-history":[{"count":1,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/745295\/revisions"}],"predecessor-version":[{"id":3674707,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/745295\/revisions\/3674707"}],"wp:attachment":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/media?parent=745295"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/tags?post=745295"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}